# The PRE-D Trial: Effect of Dapagliflozin, Metformin and Physical Activity in Pre-diabetes

> **NCT02695810** · PHASE2 · COMPLETED · sponsor: **Steno Diabetes Center Copenhagen** · enrollment: 120 (actual)

## Conditions studied

- Prediabetic State
- Obesity

## Interventions

- **DRUG:** Dapagliflozin
- **DRUG:** Metformin
- **BEHAVIORAL:** Exercise

## Key facts

- **NCT ID:** NCT02695810
- **Lead sponsor:** Steno Diabetes Center Copenhagen
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-02-24
- **Primary completion:** 2018-09-20
- **Final completion:** 2019-01-13
- **Target enrollment:** 120 (ACTUAL)
- **Last updated:** 2019-10-07

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02695810

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02695810, "The PRE-D Trial: Effect of Dapagliflozin, Metformin and Physical Activity in Pre-diabetes". Retrieved via AI Analytics 2026-07-13 from https://api.ai-analytics.org/clinical/NCT02695810. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*